Aytu Bioscience (AYTU +33.6%) jumps on triple normal volume in reaction to its agreement with
Sterling Medical Devices finalizing the development of an endotracheal
catheter called Healight for the potential treatment of COVID-19.
The company in-licensed exclusive global rights to
the technology last week from Cedars-Sinai. It says it is working with
the FDA to clarify a registration path.
https://seekingalpha.com/news/3564668-aytu-bio-up-34-on-potential-device-to-treat-covidminus-19
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.